Loading...
http://jcps.bjmu.edu.cn

Table of Content

    30 December 2020, Volume 29 Issue 12
    Others
    A biography of Academician Zhicen Lou
    Journal of Chinese Pharmaceutical Sciences
    2020, 29(12):  829-831. 
    Asbtract ( 330 )   PDF (1247KB) ( 68 )  
    Related Articles | Metrics
    A biography of Academician Zhicen Lou.
    Review
    Plant pharmacophylogeny: past, present and future
    Dacheng Hao, Peigen Xiao
    2020, 29(12):  831-854.  DOI: 10.5246/jcps.2020.12.075
    Asbtract ( 784 )   HTML ( 494)   PDF (1977KB) ( 218 )  
    Figures and Tables | References | Related Articles | Metrics

    The concept of "pharmacophylogeny" was proposed by Peigen Xiao in the 1980s based on long-term studies of Chinese researchers since ancient times and especially the 1950s. The complicated relationships and connectivity between kinship of medicinal plants, their chemical profiles and therapeutic utilities are consistent goals of pharmacophylogeny studies, which benefit innovative drug R&D. In the present work, we reviewed the origin and a brief history of research in this field, as well as the status quo and recent progress of pharmacophylogeny. The concept "pharmacophylogenomics" is put forward to represent the expanding utility of pharmacophylogeny in botanical drug R&D. Pharmacophylogeny and pharmacophylogenomics are the synthesis of multiple disciplines, such as chemotaxonomy, plant morphology, plant biochemistry/molecular biology and omics, etc. Medicinal plants within the same phylogenetic groups may have the same or similar therapeutic compounds/effects, thus forming the core of pharmacophylogeny, which is the scientific law summed up from practice and applied to practice after refining and sublimation. In the past, pharmacophylogeny plays a big role in looking for alternative resources of imported drugs in China. At present, it continues to play an active role in expanding medicinal plant resources, quality control/identification of herbal medicines, as well as predicting the chemical constituents or active ingredients of herbal medicine and the identification and determination of chemical constituents. In the ongoing future, it will play a bigger role in the search for new drugs, sorting out, summarizing, and improving herbal medicine experiences, thus boosting the sustainable conservation and utilization of traditional/natural?medicinal resources.

    Original articles
    Comparative authentication of crude drugs from subgenus Asarum species in China based on microscopic features
    Yaoli Li, Zhong Liu, Jie Yu, Mingying Shang, Baibo Xie, Feng Xu, Shao-Qing Cai
    2020, 29(12):  855-867.  DOI: 10.5246/jcps.2020.12.076
    Asbtract ( 439 )   HTML ( 145)   PDF (4088KB) ( 75 )  
    Figures and Tables | References | Related Articles | Metrics

    According to the Chinese Pharmacopoeia, the Chinese medicinal material (Asari Radix et Rhizoma) Xixin is derived from the species Asarum heterotropoides var. mandshuricum, A. sieboldii, and A. sieboldii var. seoulense. However, many species of the genus Asarum are labeled as "Xixin", "Tu-Xixin" or "Nan-Xixin" for sale in producing areas. To distinguish Chinese Asarum species and to ensure their safety and efficacy, we examined the microscopic characteristics of subg. Asarum plants in China (including subg. Asarum plants in the classification system of Flora Reipublicae Popularis Sinicae and the later published Asarum yunnanense) using a hand microtome and a microscopic digital imaging system based on our previous research. Microscopic features of the blades, petioles, and roots of A. yunnanense were investigated for the first time. Moreover, we compared nine species and one variety of the subg. Asarum (i.e. , A. yunnanense, A. caudigerellum, A. himalaicum, A. pulchellum, A. debile, A. caulescens, A. renicordatum, A. caudigerum, A. caudigerum var. cardiophyllum and A. geophilum) in China based on microscopic characteristics of the blades. Several parameters, such as morphological characteristics and distribution of hairs on both upper and lower leaf epidermises; morphological characteristics of hair cells; anticlinal walls of lower epidermal cells; size relationship between outer periclinal walls and cavity outlines of oil cells on lower leaf epidermis; presence or absence of the irregular cells containing red to brown substances among mesophyll cells; and the diameter of the largest vessels in midribs of the blades, were used for discrimination among species. To the best of our knowledge, we provided the first identification key for the 10 taxa based on blade microscopic characteristics that could be used to distinguish these taxa. Based on the key, 23 commercial samples collected from seven provinces of China were authenticated as whole dried herbs of A. himalaicum, A. caudigerellum, A. caudigerum, A. pulchellum and A. caulescens. These findings indicated that microscopic approach and related techniques were convenient and feasible and could be used for the authentication of crude drugs from Chinese subg. Asarum species.

    Intestinal anti-inflammatory effects of main components of the fruits of Euodia rutaecarpa in a co-culture model of the human colorectal adenocarcinoma cells and RAW264.7 macrophages
    Shi Wang, Lu Liu, Youbo Zhang, Wei Xu, Xiuwei Yang
    2020, 29(12):  868-879.  DOI: 10.5246/jcps.2020.12.077
    Asbtract ( 399 )   HTML ( 141)   PDF (2335KB) ( 155 )  
    Figures and Tables | References | Related Articles | Metrics

    Alkaloids are the main active constituents of the nearly ripe fruits of Euodia rutaecarpa (Juss.) Benth., which possesses antitumor, anti-inflammatory, analgesic and antimicrobial activities. In this study, we aimed to assess the potential anti-inflammatory effects of six main components, evodiamine, rutaecarpine, dehydroevodiamine, evocarpine, dihydroevocarpine and 1-methyl-2-undecyl-4-(1H)-quinolone, in the nearly ripe fruits of E. rutaecarpa. In the co-culture system consisting of the human colorectal adenocarcinoma (Caco-2) cells and RAW264.7 macrophages, inflammation was induced in RAW264.7 cells with 2 μg/mL lipopolysaccharide. The results indicated that evodiamine, rutaecarpine, and dehydroevodiamine significantly down-regulated the mRNA expressions of pro-inflammatory cytokines (Il-6, Il-1β and Tnf-α) and inflammatory mediators, such as cyclooxygenase-2 (Cox-2) and inducible nitric oxide synthase (iNos). Besides, the drug administration group showed a higher transepithelial electrical resistance and a lower tight junction permeability compared with the model group. Taken together, the tested compounds possessed anti-inflammatory effects. Our findings laid the foundation for further research on the anti-inflammatory mechanism of the nearly ripe fruits of E. rutaecarpa.

    Protective effect of hydroxysafflor yellow A on Parkinson cell model and its network pharmacology analysis
    Shuang Li, Chunyan Guo, Shuangshuang Li, Sihan You, Xiujuan Yu
    2020, 29(12):  880-895.  DOI: 10.5246/jcps.2020.12.078
    Asbtract ( 374 )   HTML ( 18)   PDF (4850KB) ( 166 )  
    Figures and Tables | References | Related Articles | Metrics

    As an effective component of safflower, hydroxysafflor yellow A (HSYA) has the effect of promoting blood circulation, removing blood stasis, and relieving pain, and it has a certain effect on blood stasis and wind-induced Parkinson’s disease (PD). However, the current research mostly involves a single intervention mechanism, which is not conducive to the clinical transformation of this type of drugs. In the present study, rotenone was used to construct a PD cell model, and the protective effect of HSYA on the PD cell model was evaluated by cell viability and mitochondrial membrane potential. TTD database was used to query PD-related therapeutic targets, Swiss Target Prediction database to query HSYA-related targets, STRING database was used to search the gene interaction relationship of common targets, and ClueGO pathway was adopted to enrich and analyze common targets and their interaction targets, as well as to explore the comprehensive intervention mechanism. The results showed that rotenone could successfully establish the PD cell model, and HSYA had significant protective effect on PD cell model. Through the network pharmacological analysis, 36 PD-related therapeutic targets and 88 HSYA-related targets were queried. The common targets of PD and HSYA were FKBP1A, HTR1A, SLC6A4 and SLC6A3. To enrich four common targets and their interaction targets through REACTOME pathway, eight cell signal pathways were obtained, and six cell biological processes were obtained through biological process pathway enrichment.

    Quality evaluation of Polyporus umbellatus based on HPLC specific chromatogram and fingerprint analysis
    Weijuan Jia, Shizhong Chen, Jianhua Sun, Zongli Bai, Yazhuo Huang, Yuankuan Zhang, Hong Wang
    2020, 29(12):  896-907.  DOI: 10.5246/jcps.2020.12.079
    Asbtract ( 350 )   HTML ( 10)   PDF (3377KB) ( 123 )  
    Figures and Tables | References | Related Articles | Metrics

    To evaluate the quality of Polyporus umbellatus, we established a simple, repeatable and reliable method based on high performance liquid chromatography (HPLC) for specific chromatogram and fingerprint analysis, which was applied to analyze samples of medicinal materials and decoction pieces collected from different regions. Finally, ten characteristic peaks were designated in the specific chromatograms and applied to the authenticate identification of P. umbellatus samples. Nine common peaks were designated in the fingerprints, and then the similarities between 32 batches of samples were calculated. Among them, eight compounds were identified by HPLC-APCI-IT-TOF-MSn, four of which were identified in specific chromatograms and four in fingerprints. In the present study, we, for the first time, combined HPLC specific chromatograms and fingerprints for the species identification and quality evaluation of P. umbellatus. Collectively, our findings provided a new method for establishing a comprehensive quality standard of P. umbellatus.

    Integrating ancient and modern approaches to traditional Chinese medicinal authentication
    Zhongzhen Zhao, Hubiao Chen, Ping Guo, Zhitao Liang, Eric Brand, Lailai Wong, Jing Liu
    2020, 29(12):  908-914.  DOI: 10.5246/jcps.2020.12.080
    Asbtract ( 337 )   HTML ( 20)   PDF (2085KB) ( 110 )  
    References | Related Articles | Metrics

    Authentication is a key component of quality control, and the quality of Chinese medicinal materials directly impacts clinical efficacy. Chinese medicinal quality control is an important concern of the wider community, and it is intricately connected to the future and development of Chinese medicine. Macroscopic identification has been used for thousands of years in Chinese medicine, and it continues to be effective for resolving important issues related to quality control in the modern-day. However, new challenges have emerged for macroscopic identification. For example, new botanical varieties have emerged, with differences in macroscopic features related to cultivated vs. wild materials. Changes in processing methods and cultivation techniques also affect these features. Consequently, continual progress and innovation in Chinese medicinal authentication methods are needed. Macroscopic identification is based on organoleptic assessment, microscopy, and research of ancient texts, such as the Bencao. In addition to collecting information from traditional experience-based differentiation, innovation can take advantage of new technologies that can provide even more detailed, precise information about morphology. In the present review, we summarized inheritance and innovation in the scientific exposition of Chinese medicinal authentication, featuring a review of specialized publications, description of the establishment of a Chinese medicine specimen center and Chinese Medicine digital project, the expansion of authentication technologies, and the formation of a cultural project dedicated to the Compendium of Materia Medica.

    Others
    Contents of Volume 29
    Journal of Chinese Pharmaceutical Sciences
    2020, 29(12):  915-927. 
    Asbtract ( 150 )   PDF (1590KB) ( 118 )  
    Related Articles | Metrics
    Keywords Index of Volume 29
    Journal of Chinese Pharmaceutical Sciences
    2020, 29(12):  928-931. 
    Asbtract ( 150 )   PDF (1085KB) ( 53 )  
    Related Articles | Metrics
    Author Index of Volume 29
    Journal of Chinese Pharmaceutical Sciences
    2020, 29(12):  932-935. 
    Asbtract ( 175 )   PDF (1099KB) ( 63 )  
    Related Articles | Metrics
    Acknowledgements
    Journal of Chinese Pharmaceutical Sciences
    2020, 29(12):  936-936. 
    Asbtract ( 111 )   PDF (866KB) ( 146 )  
    Related Articles | Metrics